Oncology Commons^™

Splenic Rupture, Secondary To G-Csf Use For Chemotherapy Induced Neutropenia: A Case Report And Review Of Literature., Nehal Masood, Asim Jamal Shaikh, Wasim Ahmed Memon, Romana Idress

Section of Haematology/Oncology

Introduction: Chemotherapy Induced neutropenia is a frequent and serious complication of cytotoxic cancer treatment. Granulocyte colony stimulating factors (G-CSF) are frequently used to counter neutropenia, attempt rapid recovery of Patients and allow for continuation of treatment without compromise on dose, especially in curative malignancies. Generally regarded as safe, G-CSF use has been very rarely reported to have resulted in serious side effects, such as, splenic rupture. Case Presentation: We are reporting a case of a twenty years old man, who was being treated for T cell acute lymphoblastic leukemia and received colony stimulating factors for treatment of severe neutropenia and …

Physicians' Experiences With Brca1/2 Testing In Community Settings., Nancy L. Keating, Kathryn A. Stoeckert, Meredith M. Regan, Lisa Digianni, Judy E. Garber

Kathryn Sabella

Consistency Check Of Planned Adaptive Option On Helical Tomotherapy., M Schirm, S Yartsev, G Bauman, Jerry J. Battista Dr., Jacob Van Dyk

Oncology Publications

This study aims to evaluate a new Planned Adaptive software (TomoTherapy Inc., Madison, WI) of the helical tomotherapy system by retrospective verification and adaptive re-planning of radiation treatment. Four patients with different disease sites (brain, nasal cavity, lungs, prostate) were planned in duplicate using the diagnostic planning kVCT data set and MVCT studies of the first treatment fraction with the same optimization parameters for both plan types. The dosimetric characteristics of minimum, maximum, and mean dose to the targets as well as to organs at risk were compared. Both sets of plans were used for calculation of dose distributions in …

Oncolog Volume 53 Number 12, December 2008, Stephanie P. Deming, Virginia M. Mohlere

OncoLog MD Anderson's Report to Physicians (All issues)

• Mantle Cell Lymphoma
• Sparing the Nipple During Mastectomy
• House Call: Taking Medicine? Be Aware of Food-Drug Interactions

Global Analysis Of Gene Expression Changes During Retinoic Acid-Induced Growth Arrest And Differentiation Of Melanoma: Comparison To Differentially Expressed Genes In Melanocytes Vs Melanoma, Mary H. Estler, Goran Boskovic, James Denvir, Sarah Miles, Donald A. Primerano, Richard M. Niles

Biochemistry and Microbiology

BACKGROUND: The incidence of malignant melanoma has significantly increased over the last decade. Some of these malignancies are susceptible to the growth inhibitory and pro-differentiating effects of all-trans-retinoic acid (RA). The molecular changes responsible for the biological activity of RA in melanoma are not well understood.

RESULTS: In an analysis of sequential global gene expression changes during a 4-48 h RA treatment of B16 mouse melanoma cells, we found that RA increased the expression of 757 genes and decreased the expression of 737 genes. We also compared the gene expression profile (no RA treatment) between non-malignant melan-a mouse melanocytes and …

Forward, John Mendelsohn Md

Legends and Legacies Book Chapters

No abstract provided.

Preface, Elizabeth L. Travis Phd

Legends and Legacies Book Chapters

No abstract provided.

Sharon Y.R. Dent, Phd, Sharon Y.R. Dent Phd

Legends and Legacies Book Chapters

No abstract provided.

Janet M. Bruner, Md, Janet M. Bruner Md

Legends and Legacies Book Chapters

No abstract provided.

Kelly K. Hunt, Md, Kelly K. Hunt Md

Legends and Legacies Book Chapters

No abstract provided.

Eugenie S. Kleinerman, Md, Eugenie S. Kleinerman Md

Legends and Legacies Book Chapters

No abstract provided.

Karen H. Lu, Md, Karen H. Lu Md

Legends and Legacies Book Chapters

No abstract provided.

Carmen P. Escalante, Md, Carmen P. Escalante Md

Legends and Legacies Book Chapters

No abstract provided.

Ritsuko Komaki, Md, Ritsuko Komaki Md

Legends and Legacies Book Chapters

No abstract provided.

Margaret L. Kripke, Phd, Margaret L. Kripke Phd

Legends and Legacies Book Chapters

No abstract provided.

Funda Meric-Bernstam, Md, Funda Meric-Bernstam Md

Legends and Legacies Book Chapters

No abstract provided.

Elizabeth A. Grimm, Phd, Elizabeth A. Grimm Phd

Legends and Legacies Book Chapters

No abstract provided.

Guillermina Lozano, Phd, Guillermina (Gigi) Lozano Phd

Legends and Legacies Book Chapters

No abstract provided.

Razelle Kurzrock, Md, Razelle Kurzrock Md

Legends and Legacies Book Chapters

No abstract provided.

Varsha V. Gandhi, Phd, Varsha V. Gandhi

Legends and Legacies Book Chapters

No abstract provided.

Vivian H. Porche, Md, Vivian H. Porche Md

Legends and Legacies Book Chapters

No abstract provided.

Epilogue, Raymond N. Dubois Md, Phd

Legends and Legacies Book Chapters

No abstract provided.

Photo Spread, Staff

Legends and Legacies Book Chapters

No abstract provided.

Kristen J. Price, Md, Kristen J. Price Md

Legends and Legacies Book Chapters

No abstract provided.

Elizabeth L. Travis, Phd, Elizabeth L. Travis Phd

Legends and Legacies Book Chapters

No abstract provided.

Dihua Yu, Md, Phd, Dihua Yu

Legends and Legacies Book Chapters

No abstract provided.

M. Alma Rodriguez, Md, Alma Rodriguez Md

Legends and Legacies Book Chapters

No abstract provided.

Cheryl L. Walker, Phd, Cheryl L. Walker Phd

Legends and Legacies Book Chapters

No abstract provided.

Vickie R. Shannon, Md, Vickie R. Shannon Md

Legends and Legacies Book Chapters

No abstract provided.

Margaret R. Spitz, Md, Margaret R. Spitz Md

Legends and Legacies Book Chapters

No abstract provided.